Stockpickr! Your Source for Stock Ideas

Q: jim,
1 month ago i told u goldman is shorting financials,u never responded,(ok)
goldman ,and bank of america planning planning wedding bells?
Asked by ecirpm - 1 months ago - 1 answers - 26312 views
Bookmark this User - Bookmark this question - Report Abuse
A: i guess when you are the MARKET you can do as you please. bottom line. its all JINGLE @
JANGLE ho ho ho merry shortsmas chris more
Post your own answer
Q: Need some Pickr advice. If you had EMC here like I do with a cost basis of
$18.20. Would you add to your position?
Asked by BrahmSki - 1 months ago - 5 answers - 22126 views
Bookmark this User - Bookmark this question - Report Abuse
A: Shouldn't be a factor, I know, but it's the first mistake people make. more
Resolved
Q: why is sirius down so far today does any body know?
Asked by James Aneckstein - 1 months ago - 10 answers - 20221 views
Bookmark this User - Bookmark this question - Report Abuse
A: I am a siri owner but do not expect fast profits if approved I think it will have to
acquire new subscriptions with different plans and prices ( like cable TV) I looking long more
Post your own answer
Q: I have just watched Cramer say that we should not be getting into technology now
and it probably wouldn't be good idea to get in before August, but he bought 700
shares of EMC for AA today. What am I missing?
Asked by beachbum242 - 1 months ago - 24 answers - 19495 views
Bookmark this User - Bookmark this question - Report Abuse
A: I like CISCO took (CSCO)
Kathy in NJ
Holds CSCO more
Post your own answer
Q: RIG versus NOV. I have NOV. Should I get out of NOV into RIG.

Would appreciate any opinion/suggestions.
Asked by honest - 1 months ago - 14 answers - 18646 views
Bookmark this User - Bookmark this question - Report Abuse
A: No matter where oil goes in the short term, RIG's income stream is based on contracts
already in place, so it should hold up OK in a general downturn I suggest. more
Post your own answer
Q: Doesn't it look like EMC is forming a head and shoulders pattern right here? Be
careful, people continue to not give this stock any respect despite fundamentals
and valuation of assets. If it breaks down anymore, this might not be a battle
worth fighting.

Position: Long EMC
Asked by Nick from Germantown - 1 months ago - 4 answers - 17352 views
Bookmark this User - Bookmark this question - Report Abuse
A: agree more
Post your own answer
Q: Wow, is it just me or is RAD being priced for extinction? I fully understand
that the economy is slowing and that retail resides in a bad neighborhood,
generics are taking sales, the flu season is off to a slow start, and there are
integration issues with the Eckard transaction....but the break up value of the
business must be worth the current stock price. Anyone done a break up analysis
for RAD? Is this the way to even analyze the situation?
Asked by dwf995 - 1 months ago - 9 answers - 16863 views
Bookmark this User - Bookmark this question - Report Abuse
A: Shares of drug retailer and my employer Rite Aid (Disclosures: I work for RAD & own shares
of restricted stock) have been under considerable pressure during the last year, plunging
from just below $7/share to their current level near $2/share. Glancing at a 10-year chart
of Rite Aid reveals several previous occasions where the stock tanked to around this
level, providing investors and traders with the opportunity to earn returns of 2X to 5X
their money as the stock subsequently rebounded to the $5 to $10/share level. Whether the
current downturn in Rite Aid will provide similar returns remains to be seen, but overall
market weakness, economic uncertainties, and a huge increase in the short interest of the
Company at the end of December to 56.7 million shares (from 44.4 million in mid-December)
suggests that a wait and see approach may be prudent in this downturn. Specifically, I am
waiting for a meaningful decline in short interest to a level that is below the average
over the last 12 reporting periods (44.5 million shares) and at least a 10% rebound from
the 52-week low, which the stock continues to drift around during recent trading.

The most recent sell-off in Rite Aid was triggered by weak, industry-wide same-store sales
for December, which declined by 0.5% on flat prescription drug sales and front-end sales
that were down by 1.2%. The decline in December same-store sales followed increases in the
previous two months of 0.4% for October and 0.9% for November. Drug retailers cited a slow
start to the flu season and increased sales of lower-priced generic drugs (which
ironically result in higher profit margins) for the poor results. Specifically, an
unexpected recall of children’s cough and cold medications and anemic demand for
seasonal items put a dent in sales for December across the entire industry. Despite
concerns over a recession and other economic uncertainties, Rite Aid is poised to
capitalize on convenience as it expands several initiatives to improve sales and customer
service, including the following: in-store health clinics/services, expanding the number
of drive-thru locations, and in-store digital photography services. Also, with pharmacy
sales accounting for over two-thirds of total sales and a shift to higher-margin generic
drugs, the Company will benefit from demographic trends in an aging population with an
increased reliance on prescription drug therapies.

Before the same-store results, Rite Aid dropped from the $4/share level to below $3/share
after reporting disappointing 3QFY08 results with a wider than expected loss and a sales
shortfall. The Company also lowered its guidance for profitability (or lack thereof with a
wider than expected loss of $161 to $192 million now expected from $78 to $161 million),
sales ($24.3 to $24.6 billion now expected from $24.5 billion to $25.1 billion),
same-store sales growth (1% to 2% growth now expected from previous 1.3% to 3.3%), and
EBIDTA ($950 million to $1 billion now expected from previous $1 to $1.1 billion). Rite
Aid ended the quarter with 5,089 stores in operation and expects the Brooks/Eckerd
acquisition of over 1,850 stores to be fully integrated by the Fall with expected
cost-saving synergies of $200 million in FY08 and $300 million in FY09. CEO Mary Sammons
has defended concerns over the Company’s liquidity, stating that Rite Aid has a $1.7
billion revolving credit facility with virtually no restrictions and cash/equivalents of
$173 million on the balance sheet. Also, the CEO exercised options to buy 200,000 shares
of common stock at $2.75 per share in mid-October 2007, bringing her total stake to 1.4
million shares.

Looking ahead, the expected cost/operating synergies from the Brooks/Eckerd acquisition,
favorable demographic trends, increased sales of prescription/generic drugs, and a focus
on customer service/convenience makes Rite Aid a stock to buy once the stock shows signs
of recovery from making new 52-week lows and short interest begins to decline below the
average of the last 12 reporting periods (44.5 million shares). For FY09, I believe Rite
Aid can achieve EBIDTA of at least $1 billion, resulting in a price target of $5/share
based on an enterprise value (EV) to EBIDTA ratio of 10X, which includes about $6 billion
in outstanding debt and a market cap of about $4 billion at $5/share for a total EV of $10
billion. The EV/EBIDTA ratio of 10X is in-line with peers such as Walgreens (WAG) at 9.1X,
CVS at 12.6X, and Longs Drug (LDG) at 7.1X, compared to Rite Aid’s current multiple of
12.3X. Alternatively, Rite Aid could become part of industry-wide consolidation with
private equity as the most likely buyer given the leverage of the Company’s high debt
load and anti-trust concerns associated with an acquisition by industry giants Walgreens
or CVS. Also, a point often overlooked is that Jean Coutu Group is now Rite Aid’s
largest shareholder with about 252 million shares or about one-third of the Company.
However, as part of the transaction for over 1,850 Brooks/Eckerd stores, Rite Aid
benefited from an inflated stock price of $4.54 to $4.71 per share, resulting in a deal
that included $1.45 billion in cash and $1.1 billion in stock that would not be feasible
today with Jean Coutu’s stake deflated to a value of just over $500 million. Now, it
just remains to be seen whether Rite Aid can capitalize on the deal by effectively
integrating the Brooks/Eckerd stores in the form of cost savings, increased sales, and
profitability.

mikehav.com more
Post your own answer
Q: Jim - Real Estate question....

I own a "rental" property in Tampa and have another house I live in. I am
getting KILLED on my rental. I lost my tenant back in December 2006 and decided
I was putting it up for sale. 8 months later and lowering the price from 255k
to 194k I have not had a single offer.

Problem is I am a business owner and have decent credit and my business needs my
good credit. Do I walk from this pig and let the bank take it or do I continue
to make the $2500 a month payments on it and all the upkeep in order to preserve
my credit?

The impact of this house is starting to really hit home now and is straining my
business and my mind.

Is a short sale the answer?

I would hate to foreclose on the pig only to have the fed lower rates in a
month, potentially increasing demand for housing - that would be my luck.

Do I walk or do I hang loose a few more months to see if the fed does anything?

Thanks.

Phil
Tampa.
Asked by nasdaqphil - 1 months ago - 28 answers - 16320 views
Bookmark this User - Bookmark this question - Report Abuse
A: Dear Phil,

I truly feel sorry for you. Now, let's work on what you can do to cut your losses.

If you don't sell this property in the next 6 months, you understand that you will be
loosing anohter $2500/month/6 months plus lost interest (if you had invested this) ~
$16,000 to $18,000, or even more.

I would first do a search of the similar properties sold in the same are. It looks like
they must be around $190k. If so, I would see if I could make the property's curb appeal
little more attactive (by paint/shrubs/plant/flowers with very minimal costs) and reduce
the price to $170k and advertise heavily for a 2-day (Saturday/Sunday) Final Sale. I bet
that you will have many buyers, and they will bid each other out and you will get more
than $170k. Let me know it works. Good luck and best regards.
Anil
11/16/07 more
Post your own answer
Q: Should we keep buy EMC or do we wait for the IPO to come out?
Asked by sirnose - 1 months ago - 15 answers - 16245 views
Bookmark this User - Bookmark this question - Report Abuse
A: Investing resources for creating wealth!
Pet Supplies & Training needs. Global
shipping.
Finest blue nose pitbulls in its breed!
Environment News, Information,
resources!
Please visit: Coffee-Advice.com
Dog & Puppy resources, news, articles, and
more.
Got acne? Cures, Treatments, articles, and more.
Restore that classic Pontiac musclecar. Click
here.
Shop your favorite stores from across the country!

Google it here!
Latest News & Technology headlines from around
the globe. more
Post your own answer
Q: I am now questioning the independence of the picks on this site. This year I
have emailed TheStreet.com over 15 times concerning CGS and have never received
one response. CGS has nearly doubled in the last 6 months, and is up 20% the
last two weeks. Recently announced Q3 numbers showed revenues up 36% you and net
income up 450% yoy. Market cap is $80M, and there is no analyst coverage. Yet
there is virtually no mention of CGS in any publication or site such as
TheStreet.com. CGS (Chyron) is the worldwide leader in graphics generation, as
you see on CNBC, ESPN, FOX, etc. The company recently announced a contract with
NBC for the Olympics and virtually every application of NBC Universal. The
company will end 2007 with over 20% revenue growth, and 2008 looks even more
promising due to mandates to switching to HD.

It seems TheStreet.com only comments on equities that are popular. It seems to
me a financial site that brings notice to a stock like CGS before it becomes
noticed and popular would be one worth listening to. CGS will likely double
again in the next 6 to 12 months.
Asked by Antrim180 - 1 months ago - 16 answers - 15802 views
Bookmark this User - Bookmark this question - Report Abuse
A: andyking18, I assume you will graciously answers these questions:

You state "It is full of micro-caps out there that have moved alot more than this." CGS
has tripled in value over the last several years. Please list all those mico-caps that
have moved, as you say, a lot more.

You state "The real players just don't deal with these jokes!" Institutional ownership
tripled in Q4 07. I fail to see your logic that "real players" don't deal with "jokes".

It seems you are the joke. more
Post your own answer
- Previous
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- ...
- 4021
- Next

Didn't see the answer you were looking for?
Post a new question for Stockpickr’s Community.

Please be advised that the answers provided by any member of TheStreet.com or Stockpickr community represents his or her own opinions, and that none of TheStreet.com, Stockpickr or James Cramer will assess, verify or guarantee the suitability or profitability of any particular investment. You should not rely solely upon information provided on this page for purposes of transacting securities or other investments. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment.
Please report any violations of the TOS to StockpickrSupport@thestreet.com